New York · GLP-1 Telehealth
REMEVi connects New York residents with licensed NY providers for semaglutide and tirzepatide prescriptions. No insurance required. Free shipping from Manhattan to Buffalo, Albany to the Hamptons.
Why New York
Built for one of the most diverse, multilingual states in America.
3.7M+ Hispanic New Yorkers — Puerto Rican, Dominican, Mexican, Ecuadorian, Colombian. All REMEVi care is fully in English and Spanish.
From the Bronx to Buffalo, Long Island to the Adirondacks — we serve every New York ZIP code with free, discreet shipping.
Every REMEVi licensed provider treating New York patients holds an active New York State medical license and follows NYSDOH telemedicine standards.
Skip the copay, skip the commute, skip the waiting room. Complete intake from your phone — ideal for busy NYC professionals and rural patients alike.
How it works
Three simple steps. Bilingual throughout.
Answer a few medical questions from your phone. English or Spanish.
A New York-licensed clinician reviews your history and confirms candidacy within 24 hours.
Free, discreet shipping to any New York address in 3–5 business days.
Statewide
REMEVi ships to every ZIP code in New York. Major cities include:
New York is home to the fourth-largest Hispanic population in the US (3.7M+, 19% of state population) — with Puerto Rican, Dominican, and Mexican communities concentrated in NYC, plus large Ecuadorian and Colombian populations. Bilingual care isn't a feature here, it's a baseline expectation.
Medications
Compounded semaglutide and tirzepatide from FDA-registered 503B pharmacies.
$149 first month, then $279/mo
A once-weekly GLP-1 injection, with monthly dose adjustments guided by your provider.
Learn more →$249 first month, then $379/mo*
A dual GLP-1 + GIP receptor agonist, linked to higher average weight loss.
Learn more →Pricing
Pay monthly or commit for significant savings. All-inclusive — medication, clinical review, and shipping.
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
FAQ
Yes. We serve all of New York including New York City (all five boroughs), Buffalo, Rochester, Yonkers, Syracuse, Albany, and every ZIP code in the state.
Absolutely. REMEVi was built bilingual from day one. New York's Puerto Rican, Dominican, Mexican, Ecuadorian, and Colombian communities are exactly who we serve — every step of the process is available in Spanish, including clinical review and care coordination.
No. REMEVi operates on a transparent, insurance-free model — $149 for your first month, then $279/month. HSA and FSA cards are accepted.
Yes. All licensed providers who treat New York patients hold active New York State medical licenses and follow New York Department of Health telehealth standards. As of July 2026, 366 clinicians in the REMEVi clinical network hold an active New York license.
Free, discreet shipping arrives in 3–5 business days to any New York address — including NYC apartments with doormen, suburban Long Island, or upstate addresses.
Free 1-minute quiz, then a 5-minute intake if you qualify. NY-licensed clinical review within 24 hours. Free shipping statewide.
See if you qualify — $149 first monthFree · no card required
